AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
- Publication date
- 1 March 2019
- Publisher
- 'Dove Medical Press Ltd.'